HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Cohort
Absence of antiviral therapy and multiple chemotherapeutic agents increase HBV reactivation risk after TACE
No Antiviral Meds Raise Liver Cancer Risks After Chemo
This retrospective cohort study of 168 HBsAg-positive HCC patients undergoing TACE found that absence of prophylactic antiviral therapy (OR …
Many liver cancer patients with hepatitis B face avoidable risks during chemo—because they’re not getting a simple antiviral pill most alrea…
Frontiers
Apr 28, 2026
Allergy & Immunology
Sys. Review
Narrative review on ICIs in patients with viral infections and solid tumors
Cancer Immunotherapy Works Differently in Viral Infections
This narrative review synthesizes evidence on immune checkpoint inhibitors in patients with viral infections and solid tumors. It highlights…
Cancer immunotherapy can still work—and sometimes even control viruses like hepatitis or HIV—but doctors must watch for dangerous flare-ups.
Frontiers
Apr 27, 2026
Allergy & Immunology
Cohort
HBV-positive status linked to higher surgical conversion in unresectable HCC receiving triple therapy
HBV-positive linked to better outcomes in liver cancer triple therapy
This single-center retrospective cohort study evaluated triple therapy with TACE, lenvatinib, and PD-1 inhibitors in 190 patients with initi…
In unresectable liver cancer, triple therapy with TACE, lenvatinib, and PD-1 inhibitors worked better in HBV-positive patients, a small retr…
Frontiers
Apr 24, 2026
Gastroenterology
NHANES data show hepatitis B infection prevalence in US adults by race and origin
How common is hepatitis B infection among U.S. adults?
An observational analysis of National Health and Nutrition Examination Survey data examined hepatitis B virus infection prevalence among US …
Hepatitis B quietly damages the liver in U.S. adults, with infection rates varying by race and ethnicity based on national health survey dat…
CDC
Apr 3, 2026
Gastroenterology
Report describes donor-derived hepatitis B virus infections after liver transplantation
What happens when a transplanted liver carries hepatitis B?
A report describes donor-derived hepatitis B virus infections following liver transplantation in the United States. No study design, populat…
A new report describes cases where a transplanted liver carried hepatitis B virus, passing the infection from donor to recipient during surg…
CDC
Apr 3, 2026